BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11921426)

  • 1. Insulin analogues: have they changed insulin treatment and improved glycaemic control?
    Madsbad S
    Diabetes Metab Res Rev; 2002; 18 Suppl 1():S21-8. PubMed ID: 11921426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.
    Roach P
    Clin Pharmacokinet; 2008; 47(9):595-610. PubMed ID: 18698880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premixed insulin analogues for the treatment of diabetes mellitus.
    Garber AJ
    Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.
    Reynolds NA; Wagstaff AJ
    Drugs; 2004; 64(17):1957-74. PubMed ID: 15329046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus.
    Rossetti P; Porcellati F; Fanelli CG; Perriello G; Torlone E; Bolli GB
    Arch Physiol Biochem; 2008 Feb; 114(1):3-10. PubMed ID: 18465353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia and insulin analogues: is there a reduction in the incidence?
    Heinemann L
    J Diabetes Complications; 1999; 13(2):105-14. PubMed ID: 10432175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin analogues and management of diabetes mellitus.
    Vaidyanathan B; Menon PS
    Indian J Pediatr; 2000 Jun; 67(6):435-41. PubMed ID: 10932964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
    Gale EA
    Diabet Med; 2000 Mar; 17(3):209-14. PubMed ID: 10784225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insulins in the treatment of diabetes mellitus.
    Lindholm A
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):475-92. PubMed ID: 12079270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin analogues in the management of diabetes.
    Vázquez-Carrera M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?
    Heller SR; Amiel SA; Evans ML; Kong MF; Macdonald IA; Peacey SR
    Diabetes Obes Metab; 2002 Mar; 4(2):106-12. PubMed ID: 11940107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
    Esposito K; Giugliano D
    Expert Opin Biol Ther; 2012 Feb; 12(2):209-21. PubMed ID: 22214489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin glargine: the first clinically useful extended-action insulin analogue.
    Ashwell SG; Home PD
    Expert Opin Pharmacother; 2001 Nov; 2(11):1891-902. PubMed ID: 11825324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.